#29: SVNT News Savient Pharmaceuticals Obtains Temporary Restraining Order in Patent Infringement Lawsuit Against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that it was
granted late yesterday a Temporary Restraining Order (“TRO”) ...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that it has
filed a lawsuit in the U.S. District Court for the District of New ...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT), a biopharmaceutical company
focused on developing, manufacturing and marketing novel therapeutic ...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT), a biopharmaceutical company
focused on developing, manufacturing and marketing novel therapeutic ...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today reported financial
results for the three and nine months ended September 30, 2006.
Highlights...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that the
United States District Court for the District of New Jersey has
dismissed,...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) announced today that the
company will release financial results for the third quarter and nine ...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that it has
filed a lawsuit in the U.S. District Court for the District of New ...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Sept. 18, 2006--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) announced the final results of its "modified Dutch Auction" tender offer which expired at 9:00...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Sept. 12, 2006--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today preliminary results of its "modified Dutch Auction" tender offer, which expired...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Sept. 8, 2006--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT), a specialty pharmaceuticals company focused on developing, manufacturing and marketing novel...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Aug. 31, 2006--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT), a specialty pharmaceuticals company focused on developing, manufacturing and marketing novel...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Aug. 14, 2006--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) announced today that it has commenced an offer to repurchase up to 10 million shares of its common...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Aug. 8, 2006--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT), announced today results for the quarter and six months ended June 30, 2006. Total revenues for...
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Aug. 4, 2006--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT), a specialty pharmaceutical company engaged in developing, manufacturing, and marketing...